DSM ??
en De Vries wil nog acquisities (niet te grote..) plegen..
kracht en vertrouwen zou kunnen voortvloeien uit significante uitbreiding stake in kapitaal door RvB..
Leiden, June 13, 2003
“Pharming is excited to be working with DSM, a market leader in the manufacturing of therapeutic proteins,' said Dr. Francis Pinto, Chief Executive Officer of Pharming. 'Through the agreement with DSM Biologics we are now in a strong position to further the commercial development of recombinant human C1 inhibitor for Hereditary Angioedema.'